Interestingly, at week 20, glucose intolerance of the anti-BAFF Ab-treated mice was significantly higher than the control Ab-treated mice, and also higher than the anti-BAFF Ab group at 12 weeks (Figures 2E, F). This evidence concerns the gene TNFSF13B and glucose measurement.